Table 5. Risk factors assessment of subjects at risk of OSA.
Risk factors | Unadjusted | Adjusted | |||
---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | ||
Gender | |||||
Male | |||||
Female | 0.390 (0.336–0.452) | <0.001 | 0.496 (0.380–0.646) | <0.001 | |
Age | 1.026 (1.020–1.032) | <0.001 | 1.015 (1.007–1.022) | <0.001 | |
BMI | 1.182 (1.155–1.209) | <0.001 | 1.115 (1.072–1.160) | <0.001 | |
Neck circumference | 1.198 (1.171–1.225) | <0.001 | 1.048 (1.016–1.081) | 0.003 | |
Waist circumference | 1.068 (1.059–1.076) | <0.001 | 1.009 (0.995–1.024) | 0.187 | |
Smoking status | |||||
Never-smokers/former smokers | |||||
Current smokers | 1.521 (1.247–1.855) | <0.001 | 0.642 (0.497–0.830) | 0.001 | |
Alcohol use | |||||
Never-drinker/former drinkers | |||||
Current drinkers | 1.780 (1.474–2.149) | <0.01 | 1.140 (0.907–1.433) | 0.262 | |
Drinking tea | |||||
Never-drinkers/former drinkers | |||||
Current drinkers | 1.286 (1.086–1.521) | 0.003 | 0.912 (0.757–1.099) | 0.335 | |
Exercise | |||||
5–7 d/week | |||||
3–4 d/week | 0.761 (0.598–0.969) | 0.027 | 0.954 (0.736–1.237) | 0.722 | |
1–2 d/week | 0.770 (0.609–0.974) | 0.029 | 0.990 (0.765–1.281) | 0.941 | |
≤3 d/month | 0.633 (0.483–0.830) | 0.001 | 0.814 (0.607–1.092) | 0.170 | |
Never | 0.833 (0.682–1.017) | 0.072 | 1.038 (0.837–1.287) | 0.735 | |
Hypertension | |||||
Yes | 2.011 (1.693–2.388) | <0.001 | 1.268 (1.044–1.539) | 0.017 | |
No/unknown | |||||
Dyslipidemia | |||||
Yes | 1.383 (1.201–1.592) | <0.001 | 0.941 (0.795–1.114) | 0.482 | |
No | |||||
HDL-C | 0.440 (0.363–0.533) | <0.001 | 0.974 (0.760–1.248) | 0.833 | |
Triglycerides | 1.147 (1.083–1.216) | <0.001 | 1.009 (0.936–1.088) | 0814 | |
Creatinine | 1.019 (1.015–1.023) | <0.001 | 1.001 (0.997–1.006) | 0.6 | |
Uric acid | 1.004 (1.003–1.005) | <0.001 | 1.001 (1.000–1.002) | 0.082 |
OSA, obstructive sleep apnoea; OR, odds ratio; 95% CI, 95% confidence interval; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol.